Pharma & Healthcare
Global Asthma Medication Market Research Report 2024
- Mar 19, 24
- ID: 66148
- Pages: 94
- Figures: 206
- Views: 16
The global Asthma Medication market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Medication.
Report Scope
The Asthma Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals，Inc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
Segment by Type
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy
Segment by Application
Children
Adolescent
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Medication.
Report Scope
The Asthma Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals，Inc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
Segment by Type
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy
Segment by Application
Children
Adolescent
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Asthma Medication Market Overview
1.1 Product Overview and Scope of Asthma Medication
1.2 Asthma Medication Segment by Type
1.2.1 Global Asthma Medication Market Value Comparison by Type (2024-2030)
1.2.2 Quick-Relief Medications
1.2.3 Long-Term Control Medications
1.2.4 Asthma Medications During Pregnancy
1.3 Asthma Medication Segment by Application
1.3.1 Global Asthma Medication Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 Global Asthma Medication Market Size Estimates and Forecasts
1.4.1 Global Asthma Medication Revenue 2019-2030
1.4.2 Global Asthma Medication Sales 2019-2030
1.4.3 Global Asthma Medication Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma Medication Market Competition by Manufacturers
2.1 Global Asthma Medication Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma Medication Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma Medication Average Price by Manufacturers (2019-2024)
2.4 Global Asthma Medication Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Medication, Product Type & Application
2.7 Asthma Medication Market Competitive Situation and Trends
2.7.1 Asthma Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma Medication Players Market Share by Revenue
2.7.3 Global Asthma Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma Medication Retrospective Market Scenario by Region
3.1 Global Asthma Medication Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma Medication Global Asthma Medication Sales by Region: 2019-2030
3.2.1 Global Asthma Medication Sales by Region: 2019-2024
3.2.2 Global Asthma Medication Sales by Region: 2025-2030
3.3 Global Asthma Medication Global Asthma Medication Revenue by Region: 2019-2030
3.3.1 Global Asthma Medication Revenue by Region: 2019-2024
3.3.2 Global Asthma Medication Revenue by Region: 2025-2030
3.4 North America Asthma Medication Market Facts & Figures by Country
3.4.1 North America Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma Medication Sales by Country (2019-2030)
3.4.3 North America Asthma Medication Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma Medication Market Facts & Figures by Country
3.5.1 Europe Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma Medication Sales by Country (2019-2030)
3.5.3 Europe Asthma Medication Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma Medication Sales by Country (2019-2030)
3.6.3 Asia Pacific Asthma Medication Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma Medication Market Facts & Figures by Country
3.7.1 Latin America Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma Medication Sales by Country (2019-2030)
3.7.3 Latin America Asthma Medication Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma Medication Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma Medication Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma Medication Sales by Type (2019-2030)
4.1.1 Global Asthma Medication Sales by Type (2019-2024)
4.1.2 Global Asthma Medication Sales by Type (2025-2030)
4.1.3 Global Asthma Medication Sales Market Share by Type (2019-2030)
4.2 Global Asthma Medication Revenue by Type (2019-2030)
4.2.1 Global Asthma Medication Revenue by Type (2019-2024)
4.2.2 Global Asthma Medication Revenue by Type (2025-2030)
4.2.3 Global Asthma Medication Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Medication Price by Type (2019-2030)
5 Segment by Application
5.1 Global Asthma Medication Sales by Application (2019-2030)
5.1.1 Global Asthma Medication Sales by Application (2019-2024)
5.1.2 Global Asthma Medication Sales by Application (2025-2030)
5.1.3 Global Asthma Medication Sales Market Share by Application (2019-2030)
5.2 Global Asthma Medication Revenue by Application (2019-2030)
5.2.1 Global Asthma Medication Revenue by Application (2019-2024)
5.2.2 Global Asthma Medication Revenue by Application (2025-2030)
5.2.3 Global Asthma Medication Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Medication Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dulera
6.1.1 Dulera Corporation Information
6.1.2 Dulera Description and Business Overview
6.1.3 Dulera Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dulera Asthma Medication Product Portfolio
6.1.5 Dulera Recent Developments/Updates
6.2 QVAR
6.2.1 QVAR Corporation Information
6.2.2 QVAR Description and Business Overview
6.2.3 QVAR Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.2.4 QVAR Asthma Medication Product Portfolio
6.2.5 QVAR Recent Developments/Updates
6.3 Glaxosmithkline plc
6.3.1 Glaxosmithkline plc Corporation Information
6.3.2 Glaxosmithkline plc Description and Business Overview
6.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glaxosmithkline plc Asthma Medication Product Portfolio
6.3.5 Glaxosmithkline plc Recent Developments/Updates
6.4 MAP Pharmaceuticals，Inc
6.4.1 MAP Pharmaceuticals，Inc Corporation Information
6.4.2 MAP Pharmaceuticals，Inc Description and Business Overview
6.4.3 MAP Pharmaceuticals，Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MAP Pharmaceuticals，Inc Asthma Medication Product Portfolio
6.4.5 MAP Pharmaceuticals，Inc Recent Developments/Updates
6.5 Merck & Co. Inc
6.5.1 Merck & Co. Inc Corporation Information
6.5.2 Merck & Co. Inc Description and Business Overview
6.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck & Co. Inc Asthma Medication Product Portfolio
6.5.5 Merck & Co. Inc Recent Developments/Updates
6.6 AstraZeneca plc
6.6.1 AstraZeneca plc Corporation Information
6.6.2 AstraZeneca plc Description and Business Overview
6.6.3 AstraZeneca plc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca plc Asthma Medication Product Portfolio
6.6.5 AstraZeneca plc Recent Developments/Updates
6.7 Roche Holdings Ltd
6.6.1 Roche Holdings Ltd Corporation Information
6.6.2 Roche Holdings Ltd Description and Business Overview
6.6.3 Roche Holdings Ltd Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Holdings Ltd Asthma Medication Product Portfolio
6.7.5 Roche Holdings Ltd Recent Developments/Updates
6.8 Genentech Inc
6.8.1 Genentech Inc Corporation Information
6.8.2 Genentech Inc Description and Business Overview
6.8.3 Genentech Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Genentech Inc Asthma Medication Product Portfolio
6.8.5 Genentech Inc Recent Developments/Updates
6.9 Sepracor, Inc
6.9.1 Sepracor, Inc Corporation Information
6.9.2 Sepracor, Inc Description and Business Overview
6.9.3 Sepracor, Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sepracor, Inc Asthma Medication Product Portfolio
6.9.5 Sepracor, Inc Recent Developments/Updates
6.10 Schering-Plough Corp
6.10.1 Schering-Plough Corp Corporation Information
6.10.2 Schering-Plough Corp Description and Business Overview
6.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Schering-Plough Corp Asthma Medication Product Portfolio
6.10.5 Schering-Plough Corp Recent Developments/Updates
6.11 Sanofi-Aventis
6.11.1 Sanofi-Aventis Corporation Information
6.11.2 Sanofi-Aventis Asthma Medication Description and Business Overview
6.11.3 Sanofi-Aventis Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sanofi-Aventis Asthma Medication Product Portfolio
6.11.5 Sanofi-Aventis Recent Developments/Updates
6.12 Theravance Inc
6.12.1 Theravance Inc Corporation Information
6.12.2 Theravance Inc Asthma Medication Description and Business Overview
6.12.3 Theravance Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Theravance Inc Asthma Medication Product Portfolio
6.12.5 Theravance Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Medication Industry Chain Analysis
7.2 Asthma Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Medication Production Mode & Process
7.4 Asthma Medication Sales and Marketing
7.4.1 Asthma Medication Sales Channels
7.4.2 Asthma Medication Distributors
7.5 Asthma Medication Customers
8 Asthma Medication Market Dynamics
8.1 Asthma Medication Industry Trends
8.2 Asthma Medication Market Drivers
8.3 Asthma Medication Market Challenges
8.4 Asthma Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Asthma Medication
1.2 Asthma Medication Segment by Type
1.2.1 Global Asthma Medication Market Value Comparison by Type (2024-2030)
1.2.2 Quick-Relief Medications
1.2.3 Long-Term Control Medications
1.2.4 Asthma Medications During Pregnancy
1.3 Asthma Medication Segment by Application
1.3.1 Global Asthma Medication Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 Global Asthma Medication Market Size Estimates and Forecasts
1.4.1 Global Asthma Medication Revenue 2019-2030
1.4.2 Global Asthma Medication Sales 2019-2030
1.4.3 Global Asthma Medication Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma Medication Market Competition by Manufacturers
2.1 Global Asthma Medication Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma Medication Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma Medication Average Price by Manufacturers (2019-2024)
2.4 Global Asthma Medication Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Medication, Product Type & Application
2.7 Asthma Medication Market Competitive Situation and Trends
2.7.1 Asthma Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma Medication Players Market Share by Revenue
2.7.3 Global Asthma Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma Medication Retrospective Market Scenario by Region
3.1 Global Asthma Medication Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma Medication Global Asthma Medication Sales by Region: 2019-2030
3.2.1 Global Asthma Medication Sales by Region: 2019-2024
3.2.2 Global Asthma Medication Sales by Region: 2025-2030
3.3 Global Asthma Medication Global Asthma Medication Revenue by Region: 2019-2030
3.3.1 Global Asthma Medication Revenue by Region: 2019-2024
3.3.2 Global Asthma Medication Revenue by Region: 2025-2030
3.4 North America Asthma Medication Market Facts & Figures by Country
3.4.1 North America Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma Medication Sales by Country (2019-2030)
3.4.3 North America Asthma Medication Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma Medication Market Facts & Figures by Country
3.5.1 Europe Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma Medication Sales by Country (2019-2030)
3.5.3 Europe Asthma Medication Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma Medication Sales by Country (2019-2030)
3.6.3 Asia Pacific Asthma Medication Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma Medication Market Facts & Figures by Country
3.7.1 Latin America Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma Medication Sales by Country (2019-2030)
3.7.3 Latin America Asthma Medication Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma Medication Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma Medication Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma Medication Sales by Type (2019-2030)
4.1.1 Global Asthma Medication Sales by Type (2019-2024)
4.1.2 Global Asthma Medication Sales by Type (2025-2030)
4.1.3 Global Asthma Medication Sales Market Share by Type (2019-2030)
4.2 Global Asthma Medication Revenue by Type (2019-2030)
4.2.1 Global Asthma Medication Revenue by Type (2019-2024)
4.2.2 Global Asthma Medication Revenue by Type (2025-2030)
4.2.3 Global Asthma Medication Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Medication Price by Type (2019-2030)
5 Segment by Application
5.1 Global Asthma Medication Sales by Application (2019-2030)
5.1.1 Global Asthma Medication Sales by Application (2019-2024)
5.1.2 Global Asthma Medication Sales by Application (2025-2030)
5.1.3 Global Asthma Medication Sales Market Share by Application (2019-2030)
5.2 Global Asthma Medication Revenue by Application (2019-2030)
5.2.1 Global Asthma Medication Revenue by Application (2019-2024)
5.2.2 Global Asthma Medication Revenue by Application (2025-2030)
5.2.3 Global Asthma Medication Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Medication Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dulera
6.1.1 Dulera Corporation Information
6.1.2 Dulera Description and Business Overview
6.1.3 Dulera Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dulera Asthma Medication Product Portfolio
6.1.5 Dulera Recent Developments/Updates
6.2 QVAR
6.2.1 QVAR Corporation Information
6.2.2 QVAR Description and Business Overview
6.2.3 QVAR Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.2.4 QVAR Asthma Medication Product Portfolio
6.2.5 QVAR Recent Developments/Updates
6.3 Glaxosmithkline plc
6.3.1 Glaxosmithkline plc Corporation Information
6.3.2 Glaxosmithkline plc Description and Business Overview
6.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glaxosmithkline plc Asthma Medication Product Portfolio
6.3.5 Glaxosmithkline plc Recent Developments/Updates
6.4 MAP Pharmaceuticals，Inc
6.4.1 MAP Pharmaceuticals，Inc Corporation Information
6.4.2 MAP Pharmaceuticals，Inc Description and Business Overview
6.4.3 MAP Pharmaceuticals，Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MAP Pharmaceuticals，Inc Asthma Medication Product Portfolio
6.4.5 MAP Pharmaceuticals，Inc Recent Developments/Updates
6.5 Merck & Co. Inc
6.5.1 Merck & Co. Inc Corporation Information
6.5.2 Merck & Co. Inc Description and Business Overview
6.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck & Co. Inc Asthma Medication Product Portfolio
6.5.5 Merck & Co. Inc Recent Developments/Updates
6.6 AstraZeneca plc
6.6.1 AstraZeneca plc Corporation Information
6.6.2 AstraZeneca plc Description and Business Overview
6.6.3 AstraZeneca plc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca plc Asthma Medication Product Portfolio
6.6.5 AstraZeneca plc Recent Developments/Updates
6.7 Roche Holdings Ltd
6.6.1 Roche Holdings Ltd Corporation Information
6.6.2 Roche Holdings Ltd Description and Business Overview
6.6.3 Roche Holdings Ltd Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Holdings Ltd Asthma Medication Product Portfolio
6.7.5 Roche Holdings Ltd Recent Developments/Updates
6.8 Genentech Inc
6.8.1 Genentech Inc Corporation Information
6.8.2 Genentech Inc Description and Business Overview
6.8.3 Genentech Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Genentech Inc Asthma Medication Product Portfolio
6.8.5 Genentech Inc Recent Developments/Updates
6.9 Sepracor, Inc
6.9.1 Sepracor, Inc Corporation Information
6.9.2 Sepracor, Inc Description and Business Overview
6.9.3 Sepracor, Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sepracor, Inc Asthma Medication Product Portfolio
6.9.5 Sepracor, Inc Recent Developments/Updates
6.10 Schering-Plough Corp
6.10.1 Schering-Plough Corp Corporation Information
6.10.2 Schering-Plough Corp Description and Business Overview
6.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Schering-Plough Corp Asthma Medication Product Portfolio
6.10.5 Schering-Plough Corp Recent Developments/Updates
6.11 Sanofi-Aventis
6.11.1 Sanofi-Aventis Corporation Information
6.11.2 Sanofi-Aventis Asthma Medication Description and Business Overview
6.11.3 Sanofi-Aventis Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sanofi-Aventis Asthma Medication Product Portfolio
6.11.5 Sanofi-Aventis Recent Developments/Updates
6.12 Theravance Inc
6.12.1 Theravance Inc Corporation Information
6.12.2 Theravance Inc Asthma Medication Description and Business Overview
6.12.3 Theravance Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Theravance Inc Asthma Medication Product Portfolio
6.12.5 Theravance Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Medication Industry Chain Analysis
7.2 Asthma Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Medication Production Mode & Process
7.4 Asthma Medication Sales and Marketing
7.4.1 Asthma Medication Sales Channels
7.4.2 Asthma Medication Distributors
7.5 Asthma Medication Customers
8 Asthma Medication Market Dynamics
8.1 Asthma Medication Industry Trends
8.2 Asthma Medication Market Drivers
8.3 Asthma Medication Market Challenges
8.4 Asthma Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Asthma Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Asthma Medication Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Asthma Medication Market Competitive Situation by Manufacturers in 2023
Table 4. Global Asthma Medication Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Asthma Medication Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Asthma Medication Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Asthma Medication Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Asthma Medication Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Asthma Medication, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Asthma Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Asthma Medication, Product Type & Application
Table 12. Global Key Manufacturers of Asthma Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Asthma Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Medication as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Asthma Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Asthma Medication Sales by Region (2019-2024) & (K Units)
Table 18. Global Asthma Medication Sales Market Share by Region (2019-2024)
Table 19. Global Asthma Medication Sales by Region (2025-2030) & (K Units)
Table 20. Global Asthma Medication Sales Market Share by Region (2025-2030)
Table 21. Global Asthma Medication Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Asthma Medication Revenue Market Share by Region (2019-2024)
Table 23. Global Asthma Medication Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Asthma Medication Revenue Market Share by Region (2025-2030)
Table 25. North America Asthma Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Asthma Medication Sales by Country (2019-2024) & (K Units)
Table 27. North America Asthma Medication Sales by Country (2025-2030) & (K Units)
Table 28. North America Asthma Medication Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Asthma Medication Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Asthma Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Asthma Medication Sales by Country (2019-2024) & (K Units)
Table 32. Europe Asthma Medication Sales by Country (2025-2030) & (K Units)
Table 33. Europe Asthma Medication Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Asthma Medication Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Asthma Medication Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Asthma Medication Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Asthma Medication Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Asthma Medication Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Asthma Medication Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Asthma Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Asthma Medication Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Asthma Medication Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Asthma Medication Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Asthma Medication Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Asthma Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Asthma Medication Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Asthma Medication Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Asthma Medication Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Asthma Medication Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Asthma Medication Sales (K Units) by Type (2019-2024)
Table 51. Global Asthma Medication Sales (K Units) by Type (2025-2030)
Table 52. Global Asthma Medication Sales Market Share by Type (2019-2024)
Table 53. Global Asthma Medication Sales Market Share by Type (2025-2030)
Table 54. Global Asthma Medication Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Asthma Medication Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Asthma Medication Revenue Market Share by Type (2019-2024)
Table 57. Global Asthma Medication Revenue Market Share by Type (2025-2030)
Table 58. Global Asthma Medication Price (USD/Unit) by Type (2019-2024)
Table 59. Global Asthma Medication Price (USD/Unit) by Type (2025-2030)
Table 60. Global Asthma Medication Sales (K Units) by Application (2019-2024)
Table 61. Global Asthma Medication Sales (K Units) by Application (2025-2030)
Table 62. Global Asthma Medication Sales Market Share by Application (2019-2024)
Table 63. Global Asthma Medication Sales Market Share by Application (2025-2030)
Table 64. Global Asthma Medication Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Asthma Medication Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Asthma Medication Revenue Market Share by Application (2019-2024)
Table 67. Global Asthma Medication Revenue Market Share by Application (2025-2030)
Table 68. Global Asthma Medication Price (USD/Unit) by Application (2019-2024)
Table 69. Global Asthma Medication Price (USD/Unit) by Application (2025-2030)
Table 70. Dulera Corporation Information
Table 71. Dulera Description and Business Overview
Table 72. Dulera Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Dulera Asthma Medication Product
Table 74. Dulera Recent Developments/Updates
Table 75. QVAR Corporation Information
Table 76. QVAR Description and Business Overview
Table 77. QVAR Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. QVAR Asthma Medication Product
Table 79. QVAR Recent Developments/Updates
Table 80. Glaxosmithkline plc Corporation Information
Table 81. Glaxosmithkline plc Description and Business Overview
Table 82. Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Glaxosmithkline plc Asthma Medication Product
Table 84. Glaxosmithkline plc Recent Developments/Updates
Table 85. MAP Pharmaceuticals，Inc Corporation Information
Table 86. MAP Pharmaceuticals，Inc Description and Business Overview
Table 87. MAP Pharmaceuticals，Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. MAP Pharmaceuticals，Inc Asthma Medication Product
Table 89. MAP Pharmaceuticals，Inc Recent Developments/Updates
Table 90. Merck & Co. Inc Corporation Information
Table 91. Merck & Co. Inc Description and Business Overview
Table 92. Merck & Co. Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck & Co. Inc Asthma Medication Product
Table 94. Merck & Co. Inc Recent Developments/Updates
Table 95. AstraZeneca plc Corporation Information
Table 96. AstraZeneca plc Description and Business Overview
Table 97. AstraZeneca plc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. AstraZeneca plc Asthma Medication Product
Table 99. AstraZeneca plc Recent Developments/Updates
Table 100. Roche Holdings Ltd Corporation Information
Table 101. Roche Holdings Ltd Description and Business Overview
Table 102. Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Roche Holdings Ltd Asthma Medication Product
Table 104. Roche Holdings Ltd Recent Developments/Updates
Table 105. Genentech Inc Corporation Information
Table 106. Genentech Inc Description and Business Overview
Table 107. Genentech Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Genentech Inc Asthma Medication Product
Table 109. Genentech Inc Recent Developments/Updates
Table 110. Sepracor, Inc Corporation Information
Table 111. Sepracor, Inc Description and Business Overview
Table 112. Sepracor, Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Sepracor, Inc Asthma Medication Product
Table 114. Sepracor, Inc Recent Developments/Updates
Table 115. Schering-Plough Corp Corporation Information
Table 116. Schering-Plough Corp Description and Business Overview
Table 117. Schering-Plough Corp Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Schering-Plough Corp Asthma Medication Product
Table 119. Schering-Plough Corp Recent Developments/Updates
Table 120. Sanofi-Aventis Corporation Information
Table 121. Sanofi-Aventis Description and Business Overview
Table 122. Sanofi-Aventis Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Sanofi-Aventis Asthma Medication Product
Table 124. Sanofi-Aventis Recent Developments/Updates
Table 125. Theravance Inc Corporation Information
Table 126. Theravance Inc Description and Business Overview
Table 127. Theravance Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Theravance Inc Asthma Medication Product
Table 129. Theravance Inc Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Asthma Medication Distributors List
Table 133. Asthma Medication Customers List
Table 134. Asthma Medication Market Trends
Table 135. Asthma Medication Market Drivers
Table 136. Asthma Medication Market Challenges
Table 137. Asthma Medication Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Asthma Medication
Figure 2. Global Asthma Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Asthma Medication Market Share by Type in 2023 & 2030
Figure 4. Quick-Relief Medications Product Picture
Figure 5. Long-Term Control Medications Product Picture
Figure 6. Asthma Medications During Pregnancy Product Picture
Figure 7. Global Asthma Medication Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Asthma Medication Market Share by Application in 2023 & 2030
Figure 9. Children
Figure 10. Adolescent
Figure 11. Adult
Figure 12. Global Asthma Medication Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Asthma Medication Market Size (2019-2030) & (US$ Million)
Figure 14. Global Asthma Medication Sales (2019-2030) & (K Units)
Figure 15. Global Asthma Medication Average Price (USD/Unit) & (2019-2030)
Figure 16. Asthma Medication Report Years Considered
Figure 17. Asthma Medication Sales Share by Manufacturers in 2023
Figure 18. Global Asthma Medication Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Asthma Medication Players: Market Share by Revenue in 2023
Figure 20. Asthma Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Asthma Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Asthma Medication Sales Market Share by Country (2019-2030)
Figure 23. North America Asthma Medication Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Asthma Medication Sales Market Share by Country (2019-2030)
Figure 27. Europe Asthma Medication Revenue Market Share by Country (2019-2030)
Figure 28. Germany Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Asthma Medication Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Asthma Medication Revenue Market Share by Region (2019-2030)
Figure 35. China Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Asthma Medication Sales Market Share by Country (2019-2030)
Figure 46. Latin America Asthma Medication Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Asthma Medication Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Asthma Medication Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Asthma Medication by Type (2019-2030)
Figure 56. Global Revenue Market Share of Asthma Medication by Type (2019-2030)
Figure 57. Global Asthma Medication Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Asthma Medication by Application (2019-2030)
Figure 59. Global Revenue Market Share of Asthma Medication by Application (2019-2030)
Figure 60. Global Asthma Medication Price (USD/Unit) by Application (2019-2030)
Figure 61. Asthma Medication Value Chain
Figure 62. Asthma Medication Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Asthma Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Asthma Medication Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Asthma Medication Market Competitive Situation by Manufacturers in 2023
Table 4. Global Asthma Medication Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Asthma Medication Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Asthma Medication Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Asthma Medication Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Asthma Medication Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Asthma Medication, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Asthma Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Asthma Medication, Product Type & Application
Table 12. Global Key Manufacturers of Asthma Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Asthma Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Medication as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Asthma Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Asthma Medication Sales by Region (2019-2024) & (K Units)
Table 18. Global Asthma Medication Sales Market Share by Region (2019-2024)
Table 19. Global Asthma Medication Sales by Region (2025-2030) & (K Units)
Table 20. Global Asthma Medication Sales Market Share by Region (2025-2030)
Table 21. Global Asthma Medication Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Asthma Medication Revenue Market Share by Region (2019-2024)
Table 23. Global Asthma Medication Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Asthma Medication Revenue Market Share by Region (2025-2030)
Table 25. North America Asthma Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Asthma Medication Sales by Country (2019-2024) & (K Units)
Table 27. North America Asthma Medication Sales by Country (2025-2030) & (K Units)
Table 28. North America Asthma Medication Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Asthma Medication Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Asthma Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Asthma Medication Sales by Country (2019-2024) & (K Units)
Table 32. Europe Asthma Medication Sales by Country (2025-2030) & (K Units)
Table 33. Europe Asthma Medication Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Asthma Medication Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Asthma Medication Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Asthma Medication Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Asthma Medication Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Asthma Medication Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Asthma Medication Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Asthma Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Asthma Medication Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Asthma Medication Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Asthma Medication Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Asthma Medication Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Asthma Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Asthma Medication Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Asthma Medication Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Asthma Medication Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Asthma Medication Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Asthma Medication Sales (K Units) by Type (2019-2024)
Table 51. Global Asthma Medication Sales (K Units) by Type (2025-2030)
Table 52. Global Asthma Medication Sales Market Share by Type (2019-2024)
Table 53. Global Asthma Medication Sales Market Share by Type (2025-2030)
Table 54. Global Asthma Medication Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Asthma Medication Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Asthma Medication Revenue Market Share by Type (2019-2024)
Table 57. Global Asthma Medication Revenue Market Share by Type (2025-2030)
Table 58. Global Asthma Medication Price (USD/Unit) by Type (2019-2024)
Table 59. Global Asthma Medication Price (USD/Unit) by Type (2025-2030)
Table 60. Global Asthma Medication Sales (K Units) by Application (2019-2024)
Table 61. Global Asthma Medication Sales (K Units) by Application (2025-2030)
Table 62. Global Asthma Medication Sales Market Share by Application (2019-2024)
Table 63. Global Asthma Medication Sales Market Share by Application (2025-2030)
Table 64. Global Asthma Medication Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Asthma Medication Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Asthma Medication Revenue Market Share by Application (2019-2024)
Table 67. Global Asthma Medication Revenue Market Share by Application (2025-2030)
Table 68. Global Asthma Medication Price (USD/Unit) by Application (2019-2024)
Table 69. Global Asthma Medication Price (USD/Unit) by Application (2025-2030)
Table 70. Dulera Corporation Information
Table 71. Dulera Description and Business Overview
Table 72. Dulera Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Dulera Asthma Medication Product
Table 74. Dulera Recent Developments/Updates
Table 75. QVAR Corporation Information
Table 76. QVAR Description and Business Overview
Table 77. QVAR Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. QVAR Asthma Medication Product
Table 79. QVAR Recent Developments/Updates
Table 80. Glaxosmithkline plc Corporation Information
Table 81. Glaxosmithkline plc Description and Business Overview
Table 82. Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Glaxosmithkline plc Asthma Medication Product
Table 84. Glaxosmithkline plc Recent Developments/Updates
Table 85. MAP Pharmaceuticals，Inc Corporation Information
Table 86. MAP Pharmaceuticals，Inc Description and Business Overview
Table 87. MAP Pharmaceuticals，Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. MAP Pharmaceuticals，Inc Asthma Medication Product
Table 89. MAP Pharmaceuticals，Inc Recent Developments/Updates
Table 90. Merck & Co. Inc Corporation Information
Table 91. Merck & Co. Inc Description and Business Overview
Table 92. Merck & Co. Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck & Co. Inc Asthma Medication Product
Table 94. Merck & Co. Inc Recent Developments/Updates
Table 95. AstraZeneca plc Corporation Information
Table 96. AstraZeneca plc Description and Business Overview
Table 97. AstraZeneca plc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. AstraZeneca plc Asthma Medication Product
Table 99. AstraZeneca plc Recent Developments/Updates
Table 100. Roche Holdings Ltd Corporation Information
Table 101. Roche Holdings Ltd Description and Business Overview
Table 102. Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Roche Holdings Ltd Asthma Medication Product
Table 104. Roche Holdings Ltd Recent Developments/Updates
Table 105. Genentech Inc Corporation Information
Table 106. Genentech Inc Description and Business Overview
Table 107. Genentech Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Genentech Inc Asthma Medication Product
Table 109. Genentech Inc Recent Developments/Updates
Table 110. Sepracor, Inc Corporation Information
Table 111. Sepracor, Inc Description and Business Overview
Table 112. Sepracor, Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Sepracor, Inc Asthma Medication Product
Table 114. Sepracor, Inc Recent Developments/Updates
Table 115. Schering-Plough Corp Corporation Information
Table 116. Schering-Plough Corp Description and Business Overview
Table 117. Schering-Plough Corp Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Schering-Plough Corp Asthma Medication Product
Table 119. Schering-Plough Corp Recent Developments/Updates
Table 120. Sanofi-Aventis Corporation Information
Table 121. Sanofi-Aventis Description and Business Overview
Table 122. Sanofi-Aventis Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Sanofi-Aventis Asthma Medication Product
Table 124. Sanofi-Aventis Recent Developments/Updates
Table 125. Theravance Inc Corporation Information
Table 126. Theravance Inc Description and Business Overview
Table 127. Theravance Inc Asthma Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Theravance Inc Asthma Medication Product
Table 129. Theravance Inc Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Asthma Medication Distributors List
Table 133. Asthma Medication Customers List
Table 134. Asthma Medication Market Trends
Table 135. Asthma Medication Market Drivers
Table 136. Asthma Medication Market Challenges
Table 137. Asthma Medication Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Asthma Medication
Figure 2. Global Asthma Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Asthma Medication Market Share by Type in 2023 & 2030
Figure 4. Quick-Relief Medications Product Picture
Figure 5. Long-Term Control Medications Product Picture
Figure 6. Asthma Medications During Pregnancy Product Picture
Figure 7. Global Asthma Medication Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Asthma Medication Market Share by Application in 2023 & 2030
Figure 9. Children
Figure 10. Adolescent
Figure 11. Adult
Figure 12. Global Asthma Medication Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Asthma Medication Market Size (2019-2030) & (US$ Million)
Figure 14. Global Asthma Medication Sales (2019-2030) & (K Units)
Figure 15. Global Asthma Medication Average Price (USD/Unit) & (2019-2030)
Figure 16. Asthma Medication Report Years Considered
Figure 17. Asthma Medication Sales Share by Manufacturers in 2023
Figure 18. Global Asthma Medication Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Asthma Medication Players: Market Share by Revenue in 2023
Figure 20. Asthma Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Asthma Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Asthma Medication Sales Market Share by Country (2019-2030)
Figure 23. North America Asthma Medication Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Asthma Medication Sales Market Share by Country (2019-2030)
Figure 27. Europe Asthma Medication Revenue Market Share by Country (2019-2030)
Figure 28. Germany Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Asthma Medication Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Asthma Medication Revenue Market Share by Region (2019-2030)
Figure 35. China Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Asthma Medication Sales Market Share by Country (2019-2030)
Figure 46. Latin America Asthma Medication Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Asthma Medication Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Asthma Medication Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Asthma Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Asthma Medication by Type (2019-2030)
Figure 56. Global Revenue Market Share of Asthma Medication by Type (2019-2030)
Figure 57. Global Asthma Medication Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Asthma Medication by Application (2019-2030)
Figure 59. Global Revenue Market Share of Asthma Medication by Application (2019-2030)
Figure 60. Global Asthma Medication Price (USD/Unit) by Application (2019-2030)
Figure 61. Asthma Medication Value Chain
Figure 62. Asthma Medication Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Vibrating Viscometer Market Insights, Forecast to 2030
Dec 16, 24
Global Specialty Hoses Market Insights, Forecast to 2030
Dec 16, 24
Global Recreational Fiberglass Boat Market Insights, Forecast to 2030
Dec 16, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232